MK-677 (Ibutamoren) – Genetix Pharma
Product Overview
MK-677 (Ibutamoren) by Genetix Pharma is an investigational growth hormone secretagogue commonly associated with research into growth hormone (GH) and IGF-1 stimulation. It is an orally active compound that mimics the action of ghrelin and is widely discussed in scientific and fitness research contexts for its effects on hormonal signaling, recovery, and body composition.
Key Features
- 15–25mg MK-677 (Ibutamoren) per tablet (varies by batch/product line)
- Manufactured by Genetix Pharma
- Oral growth hormone secretagogue (ghrelin mimetic)
- Commonly associated with GH/IGF-1 research applications
- Once-daily oral administration format
How MK-677 Works
MK-677 binds to the ghrelin receptor (GHS-R1a), stimulating the body’s natural release of growth hormone. This leads to increased circulating GH and IGF-1 levels over time, which have been studied for their potential effects on sleep quality, recovery, appetite regulation, and lean body mass support.
Clinical studies have shown measurable increases in GH and IGF-1 levels following administration, supporting its role as a potent GH secretagogue in research settings.




Reviews
There are no reviews yet.